You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letters
Aspirin dose for treatment of Kawasaki disease
  1. Thomas Krasemann
  1. Correspondence to Dr Thomas Krasemann, Paediatric Cardiology, Evelina London Children's Hospital, London SE1 7EH, UK; thomas.krasemann{at}gstt.nhs.uk

https://doi.org/10.1136/archdischild-2014-307646

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    With great interest I read the summary of the current knowledge regarding the management of Kawasaki disease.1 The authors summarise the knowledge about genetic variances contributing to the risk of acquiring Kawasaki disease. They comment that some scores like the Kobayashi score are not as predictive outside the Japanese population, and that subsequently some …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles